News | December 17, 2023
Biocon Biologics recognized as an Asia IP Elite for 2023
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
The product will be manufactured at Lupin's Pithampur facility in India
Expands patient reach to remotest towns by furthering investment in GoApptiv
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Pantoprazole Sodium Delayed-Release Tablets are indicated for short-term treatment of Erosive Esophagitis associated with GERD
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
New facility is part of Aptar Pharma’s global expansion program
Cresemba is the only azole antifungal therapy approved for pediatric patients as young as one affected by these serious, potentially life-threatening infections
Subscribe To Our Newsletter & Stay Updated
